These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8457645)
1. Effects of glycosaminoglycans on factor XI activation by thrombin. Gailani D; Broze GJ Blood Coagul Fibrinolysis; 1993 Feb; 4(1):15-20. PubMed ID: 8457645 [TBL] [Abstract][Full Text] [Related]
2. Effect of heparin on the activation of factor XI by fibrin-bound thrombin. von dem Borne PA; Meijers JC; Bouma BN Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269 [TBL] [Abstract][Full Text] [Related]
3. Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombin. Wuillemin WA; Mertens K; ten Cate H; Hack CE Br J Haematol; 1996 Feb; 92(2):466-72. PubMed ID: 8603018 [TBL] [Abstract][Full Text] [Related]
4. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Senzolo M; Coppell J; Cholongitas E; Riddell A; Triantos CK; Perry D; Burroughs AK Blood Coagul Fibrinolysis; 2007 Apr; 18(3):227-36. PubMed ID: 17413758 [TBL] [Abstract][Full Text] [Related]
5. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II. Scully MF; Ellis V; Seno N; Kakkar VV Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851 [TBL] [Abstract][Full Text] [Related]
6. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available. Wielders SJ; Béguin S; Hemker HC; Lindhout T Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1138-42. PubMed ID: 15072993 [TBL] [Abstract][Full Text] [Related]
7. The effect of acetaldehyde-glycosaminoglycan mixtures upon Factor IXa and Factor IX-Deficient Plasma. Brecher AS; Moon AR; Gray KD Alcohol; 2006 Jun; 39(2):97-104. PubMed ID: 17134662 [TBL] [Abstract][Full Text] [Related]
8. The role of factor XI in coagulation: a matter of revision. Minnema MC; Ten Cate H; Hack CE Semin Thromb Hemost; 1999; 25(4):419-28. PubMed ID: 10548074 [TBL] [Abstract][Full Text] [Related]
9. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin. Baglia FA; Walsh PN Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373 [TBL] [Abstract][Full Text] [Related]
10. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. von dem Borne PA; Cox LM; Bouma BN Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866 [TBL] [Abstract][Full Text] [Related]
11. Activation of heparin cofactor II by heparin and dermatan sulfate. Tollefsen DM Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014 [TBL] [Abstract][Full Text] [Related]
12. Energetics of thrombin-thrombomodulin interaction. Vindigni A; White CE; Komives EA; Di Cera E Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147 [TBL] [Abstract][Full Text] [Related]
13. Catalysis of thrombin inhibition provides an index for estimating the antithrombotic potential of glycosaminoglycans in rabbits. Fernandez FA; Buchanan MR; Hirsh J; Fenton JW; Ofosu FA Thromb Haemost; 1987 Jun; 57(3):286-93. PubMed ID: 3116701 [TBL] [Abstract][Full Text] [Related]
14. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis. Chang X; Yamada R; Yamamoto K Arthritis Res Ther; 2005; 7(2):R268-73. PubMed ID: 15743473 [TBL] [Abstract][Full Text] [Related]
16. In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity. McRae SJ; Stafford AR; Fredenburgh JC; Weitz JI Biochemistry; 2007 Apr; 46(13):4195-203. PubMed ID: 17343367 [TBL] [Abstract][Full Text] [Related]
17. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate. Glauser BF; Pereira MS; Monteiro RQ; Mourão PA Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257 [TBL] [Abstract][Full Text] [Related]
18. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor). Schousboe I Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361 [TBL] [Abstract][Full Text] [Related]
19. Selective binding of zinc ions to heparin rather than to other glycosaminoglycans. Parrish RF; Fair WR Biochem J; 1981 Feb; 193(2):407-10. PubMed ID: 6796046 [TBL] [Abstract][Full Text] [Related]
20. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C. Fernández JA; Petäjä J; Griffin JH Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]